DUSP1 and neoplasm: In addition, the downregulation of DUSP1 significantly correlated with a higher Gleason score, pre‐treatment prostate‐specific antigen (PSA) levels, and tumor progression in patients (Figure 7C,D; Figure S9E, Supporting Information).